Options: Hide MedDRA Preferred Terms , display all 30 labels
Information about indications was extracted from the indications and usage sections of the labels.
Indication | Labels | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Anovulatory cycle | x | ||||||||||||||||||||||
Cardiac disorder | x | ||||||||||||||||||||||
Cardiac failure | x | x | x | ||||||||||||||||||||
Cardiac failure congestive | x | x | x | x | x | ||||||||||||||||||
Diabetes mellitus | x | ||||||||||||||||||||||
Diabetic ketoacidosis | x | x | x | x | x | x | |||||||||||||||||
Insulin resistance | x | x | x | x | x | x | |||||||||||||||||
Macrovascular disease | x | x | x | x | x | x | x | x | x | ||||||||||||||
Type 1 diabetes mellitus | x | x | x | x | x | x | |||||||||||||||||
Type 2 diabetes mellitus | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | |||
Weight decreased | x | x | x | x | x | x | x | x | x | x |
standard – alternative
100% | ||
75% | ||
50% | ||
10% | ||
frequent (1% to 100%) | ||
infrequent (0.1% to 1%) | ||
rare (<0.1%) | ||
postmarketing | ||
0% | ||
no frequency information | ||
not found on label |